Veeva Announces CRO Partnership Program and First Member
Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program.
Veeva Systems announced that CRO Advanced Clinical both selected its Vault eTMF, and became the first member of its new partnership program. According to Julie Ross, Executive Vice President of Advanced Clinical, “A cloud-based eTMF gives us and our clients a strategic advantage. We can speed document collection from start-up through trial close, and our clients get the visibility they need throughout the entire study.” Through the Veeva CRO Partnership Program, Advanced Clinical received expert training and implementation support, and is prepared to deploy Vault eTMF for new and existing studies. Going forward, Advanced Clinical will receive regular checks and training on system updates. Also, as a CRO partner, they benefit from ongoing strategy sessions and Veeva’s marketing outreach.
Veeva Systems announced the new CRO partnership program to support growing trends in eTMF outsourcing and cloud adoption. In a recent Applied Clinical Trials article, http://bit.ly/I1prg6, the author observed that technology vendors are working closely with CROs in developing partner programs that benefit both the CRO as well as the sponsor. "Vendors have implemented strictly controlled, high quality training and testing programs along with user testing (certification), company accreditation and associated branding to recognize high quality CRO partners who are familiar with their technology.”
The full release can be read here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
